A variety of new N-(5-(benzofuranol-7-oxymethyl)-1,3,4-thiadiazol-2-yl)amide
compounds (8a-i) were synthesized through
four steps from benzofuranol as raw materials. The crystal structure of
compound 8a (C17H21N3O3S, Mr = 347.43) was measured
by X-ray diffraction, which was classified as monoclinic system, Z = 4, V = 1742.72(8) Å3, Dc = 1.324 Mg/m3, F(000) =
736, S = 1.03, μ = 0.21 mm-1, space group P21 with a =
9.9177(3), b = 8.9519(2), c = 19.8679(5) Å, the final R = 0.035 and wR = 0.105 for 3873 observed reflections (I > 2σ(I)). The X-ray structure presented
N(3)–H(3)···N(2) and C(6)–H(6)···O(3) intermolecular hydrogen bonds, which acted
as an important role in stabilizing the crystal structure. Additionally, preliminary
biological assay on compound 8a showed
good fungicidal activity in vivo,
with the inhibition of 75% against Pseudoperonospora
cubensis at 200 mg/L.